While down-regulation of DGAT1 in spheroids following LGALS3 silencing could have protective effects in condition of hepatic steatosis, changes in CPT1A and PPARA mRNA levels, might be a consequence of the lipid content reduction or represent an independent effect exerted by Gal-3. This evidence concerns the gene DGAT1 and fatty liver disease.